CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-01-08 | Hahn Brian M. CFO | Grant or award · Employee Stock Option (right to buy) | +61,000 | 61,000 | ||
| 2014-12-22 | HENOS MICHAEL A Director | Sale | −10,659 | $8.44 | $90K | 469,454 |
| 2014-12-19 | HENOS MICHAEL A Director | Sale | −10,598 | $8.61 | $91K | 480,113 |
| 2014-12-17 | HENOS MICHAEL A Director | Sale | −5,121 | $8.97 | $46K | 490,711 |
| 2014-12-15 | HENOS MICHAEL A Director | Option exercise | +43,628 | $0.33 | $14K | 497,436 |
| 2014-12-15 | HENOS MICHAEL A Director | Sale | −1,604 | $8.98 | $14K | 495,832 |
| 2014-12-15 | HENOS MICHAEL A Director | Option exercise · Warrant to Purchase Common Stock (right to buy) | −5,133 | 0 | ||
| 2014-12-15 | HENOS MICHAEL A Director | Option exercise · Warrant to Purchase Common Stock (right to buy) | −38,493 | 0 | ||
| 2014-07-08 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +15,401 | 15,401 | ||
| 2014-06-18 | King Rachel K. President, CEO | Option exercise | +100,000 | $1.12 | $112K | 108,706 |
| 2014-06-18 | King Rachel K. President, CEO | Option exercise · Employee Stock Option (right to buy) | −100,000 | 347,580 | ||
| 2014-06-13 | HENOS MICHAEL A Director | Purchase | +5,000 | $6.21 | $31K | 12,562 |
| 2014-06-12 | HENOS MICHAEL A Director | Purchase | +6,000 | $6.54 | $39K | 7,562 |
| 2014-04-03 | HENOS MICHAEL A Director | Option exercise | +1,562 | $1.12 | $2K | 1,562 |
| 2014-04-03 | HENOS MICHAEL A Director | Option exercise · Stock Option (right to buy) | −1,562 | 0 | ||
| 2014-03-31 | PEARSON TIMOTHY R Director | Grant or award · Stock Option (right to buy) | +15,401 | 15,401 | ||
| 2014-01-15 | Magnani John L. VP of Research, CSO | Conversion | −9,969 | 90,374 | ||
| 2014-01-15 | Magnani John L. VP of Research, CSO | Conversion · Series A-1 Preferred Stock | −32,918 | 0 | ||
| 2014-01-15 | HENOS MICHAEL A Director | Conversion | +11,936 | 22,668 | ||
| 2014-01-15 | HENOS MICHAEL A Director | Conversion | +337,579 | 453,808 |
Page 18 of 20 · 397 trades